Intrathymic maturation of T lymphocytes is characterized by variable expression of O-linked
Introduction
Most T lymphocytes of the immune system differentiate within the thymus along the CD4/CD8 developmental pathway by a highly ordered process termed thymic selection (Fowlkes and Pardoll, 1989; von Boehmer, 1994) . The maturation status of thymocytes is commonly assessed by their expression of the coreceptor proteins CD4 and CD8 and their surface density of aP T cell receptor (ap TCR) molecules (Fowlkes and Pardoll, 1989) . Three major subpopulations of T cells exist within the thymus that exemplify the progression of thymocytes along the CD4/CD8 developmental pathway: (1) CD4"CD8" (doublenegative) thymocytes, which express no/low aP TCR; (2) CD4 + CD8 + (double-positive) thymocytes, which also express no/low ap TCR; and (3) CD4 + CD8~ and CD4"CD8 + (single positive) thymocytes, both of which express high surface density of aP TCR (Figure 1 ; Fowlkes and Pardoll, 1989; von Boehmer, 1994) . Immature double-positive thymocytes are the predominant thymocyte subset, accounting for approximately 85% of T cells within the thymus (Fowlkes and Pardoll, 1989; von Boehmer, 1994) . Double-positive thymocytes expressing otp TCR of appropriate specificities are selected for further maturation into single-positive T cells, which migrate from the thymus and reside in peripheral lymphoid organs, including lymph node and spleen (Fowlkes and Pardoll, 1989; Blackman et al., 1990; von Boehmer, 1994; Weissman, 1994) .
Approximately 20 years ago, Reisner and colleagues (Reisner et al, 1976) made the notable observation that immature and mature murine thymocytes were readily separated by agglutination with the galactose-binding lectin peanut agglutinin (PNA), specific for Gaip 1,3GalNAc residues (Swamy et al, 1991) . Subsequent studies using microfluorometry confirmed that differential binding of PNA to murine thymocytes distinguished medullary (mature) and cortical (immature) thymocyte subsets, expressing low and high amounts of PNA-specific glycans, respectively (Fowlkes et al, 1980) . More recently, studies by Baum and colleagues demonstrated that conversion of human thymocytes for PNA + to PNA~ phenotype is correlated with increased expression of ot2,3 O-linked sialyltransferase (ST) that sialylates Gaipi,3GalNAc disaccharides, masking them from PNA binding (Gillespie et al, 1993 thymocytes (Gillespie et al., 1993) , suggesting that PNAspecific glycans are cyclically masked/unmasked during intrathymic T cell differentiation.
In the current report, we have extended recent findings in the human system to the study of murine thymocytes from both normal mice and transgenic mice that are blocked at the double-negative stage of thymic development. Flow cytometry analysis was used to examine expression of PNA-specific glycans on individual thymocyte subpopulations at a single cell level and biochemical studies were performed to analyze the subset of PNA-binding proteins that are recurrently masked by sialylation during T cell development. These results demonstrate that expression of PNA-specific glycans is regulated at multiple stages of T cell development and show that murine PNA-speclflc glycans on marine thymocytes thymocytes sequentially progress from PNAN stages during their differentiation. In addition, these data show that a similar set of polypeptides are variably masked by sialylation on immature and mature T cells. The implications of these findings on our current knowledge of the regulation of sialyltransferase expression during T cell development is discussed.
Results
Expression of PNA-specific glycans on immature and mature T cells Initially, expression of peanut agglutinin (PNA)-specific glycans on immature and mature T cells was examined by fluorescence activated cell sorting (FACS) analysis using fluorescein (FITC)-labeled PNA. Briefly, FACS analysis is performed by passing cells in suspension through a sensing region which is illuminated by one or more laser beams; fluorescent molecules are excited and emit light which is converted into electronic signals (Bonner et al., 1972; Parks and Herzenburg, 1972) . FACS analysis allows quantitative measurements of the surface density of specific molecules on statistically large numbers of cells at a single cell level. FACS profiles are typically displayed as one-color histograms with the relative fluorescence (log scale) on the x-axis versus cell number on the yaxis; control groups are also included (which did not receive fluorescent-labeled material or were stained with an irrelevant fluorescent-labeled Ab that does not react with the cell population) to measure autofluorescence, or background staining (Bonner et al., 1972; Parks and Herzenburg, 1972) .
High amounts of PNA-specific glycans were expressed on thymocytes compared to splenic T cells (Figure 2A ), and expression of PNA-specific glycans was significantly enhanced by sialidase treatment on both cell types ( Figure 2A ). Surface staining with FTTC-PNA was specific in that it was inhibited by increasing concentrations of galactose, but not mannose or glucose saccharides ( Figure 2B ). These data demonstrate that expression of PNA-specific glycans is highly regulated during T cell development with thymocytes expressing high surface density of PNA-specific glycans relative to splenic T cells. Moreover, these results show that variable expression of PNAspecific glycans on immature and mature T cells is regulated by sialic acid-dependent masking mechanisms.
Increased expression of PNA-specific glycans on mature T lymphocytes cultured in inhibitors of O-linked glycan elongation
Next, we examined the expression of PNA-specific glycans on mature splenic T cells cultured in the presence of the metabolic inhibitor of O-glycan elongation, benzyl-GalNAc (B-GalNAc; Nagata et al., 1994) . As previously established, B-GalNAc may be metabolized to Gal(31,3B-GalNAc, which is a potent inhibitor of sialylation by a2,3 O-linked ST (Huet et al., 1995; Sakamaki et al., 1995) . Expression of PNA-specific glycans on mature splenic T cells was significantly enhanced following overnight culture in B-GalNAc ( Figure 3A) , similar to what is observed upon sialidase treatment of T cells cultured in medium ( Figure 3A ). Increased expression of PNA-binding glycans on B-GalNAc-treated T cells was specific in that surface expression of N-linked, Concanavalin A (Con A)-binding glycans was unchanged ( Figure 3B ), and expression of PNAbinding glycans was not affected by culture in the related com- Surface expression of PNA-specific glycans was evaluated using FTTC-conjugated PNA. One color histogTams also include negative control staining (shaded curve). (B) Splenic T cells were cultured overnight at 37°C in medium in the absence or presence of 5 mM benzyl-GalNAc (B-GalNAc) or benzyl-GlcNAc (B-GlcNAc) as indicated, and surface expression of PNA-specific and Con A specific-glycans evaluated by staining with FTTC-conjugaled PNA and biotin-labeled Con A, respectively. pound benzyl-GlcNAc ( Figure 3B ). Thus, in agreement with our results using sialidase treatment in Figure 1 , these data show that metabolic inhibition of sialylation of O-linked glycans results in conversion of splenic T cells from PNA 10 to PNA W phenotype. Moreover, these results indicate that BGalNAc provides a useful strategy for inhibiting sialylation of PNA-specific glycans on T lymphocyte proteins.
Expression of PNA-specific glycans on individual thymocyte subpopulations
Recent studies on human thymus tissue suggest that PNAspecific glycans on immature double-negative thymocytes are more heavily sialylated that those on progeny double-positive thymocytes (Gillespie et al., 1993) . To investigate this issue, expression of PNA-specific glycans on individual murine thymocyte subpopulations was evaluated using three-color flow cytometry analysis. As shown in Figure 4 , expression of PNAspecific glycans on CD4 + CD8 + thymocytes was significantly increased compared to precursor CD4"CD8~ thymocytes (Figure 4 , left-hand column); similarly, immature CD4 + CD8 + thymocytes expressed high levels of PNA-specific glycans relative to mature CD4 + CD8" and mature CD4"CD8 + thymocytes (Figure 4, left-hand column) . Importantly, these data show that expression of PNA-specific glycans on all thymocyte subpopulations was increased to similar levels by sialidase treatment (Figure 4 , right-hand column), indicating that sialic aciddependent masking mechanisms function before and after the CD4 + CD8 + stage of development to sustain low surface expression of PNA-specific glycans. Low expression of PNAspecific glycans on immature CD4~CD8~ thymocytes was confirmed using thymocytes from RAG (recombinase activation gene) deficient (RAG -/-) mice, which are developmentally arrested at the CD4~CD8~ stage because they do not express gene products necessary for T cell receptor rearrangement (Shinkai et al, 1992) , ( Figure 5A ). As demonstrated, low levels of PNA-specific glycans were expressed on RAG -/-thymocytes compared to wild type (WT) thymocytes, which were significantly elevated by sialidase treatment ( Figure 5B ). Similar results were observed using immature CD4"CD8~ fetal thymocytes from normal mice (data not shown). Taken together, these results demonstrate that expression of PNA-specific glycans is highly regulated during T cell development with murine thymocytes progressing from PNA'^PNA^-^NA 10 stages during their differentiation into mature T cells.
A similar set of polypeptides is intermittently masked by sialylation during T cell development
Finally, we wished to determine if regulated expression of PNA-specific glycans involves the sialylation of a similar subset of proteins at different stages of T cell development. For these studies, mock and sialidase treated WT and RAG -/-thymocytes were surface-labeled by biotinylation, solubilized in 1% NP-40, and lysates precipitated with a PNA affinity matrix. In agreement with our results in Figure 5B , significantly greater amounts of surface proteins were present in PNA precipitates of untreated WT thymocytes compared to un- + CD8", and CD4'CD8* thymocyte subpopulations was determined by three-color surface staining analysis. Thymocytes were either mock or sialidase treated and stained using FITC-conjugated PNA, Biotin-conjugated anti-CD4, and PE-conjugated anti-CD8. The relative percentages in CD4/CD8 quadrants (top) were CD4"CD8", 6%; CD^CDS*, 85%; CD4 + CD8~, 7%; and CD4'CD8*, 2%. The surface density of PNA-specific glycans on individual thymocyte subpopulations is displayed as one-color histograms which also include negative control staining (dashed line). Thymocytes from wild type (WT) or RAG knockout (RAG -/-) mice were stained with FITC-conjugated anti-CD4 mAb and biotin-conjugated antd-CD8 mAbs; Leu4 mAbs were used as negative controls. Note that thymocyte development in RAG-/-mice is halted at the CD4~CD8~ stage. (B) Expression of PNA-specific glycans on thymocytes of wild type and RAG -/-mice was examined using FITC-conjugated PNA as in Figure 1A . Long dash, negative control; short-dash, mock treated thymocytes; solid line, sialidase-treated thymocytes. The relative increase in surface density of PNA-specific glycans following sialidase treatment was 4.4x for WT thymocytes and 8.9x for RAG -/-thymocytes.
treated RAG -/-thymocytes ( Figure 6A ), including CD8, CD8-associated protein (*), CD43, CD45, and two unknown proteins designated p65 and pl50 ( Figure 6A ); proteins were identified by preclearing with specific mAbs and precipitation/ recapture studies (Wu et ai, 1996) . Unmasking of PNAbinding glycans by sialidase treatment resulted in increased precipitation of CD43, pl50, and CD45 proteins from both RAG -/-and WT thymocytes ( Figure 6A ). Increased PNA binding of sialidase treated thymocyte proteins was specific in that equivalent amounts of CD8, CD8-associated protein (•), and p65 molecules were present in PNA precipitates of mock and sialidase treated WT thymocytes ( Figure 6A ). Interestingly, several new species were observed that were not present in PNA precipitates of mock treated cells, even on WT thymocytes ( Figure 6A, arrows) . In extension of these findings, we compared PNA precipitation of surface proteins from sialidase treated thymocytes and splenic T cells. In agreement with our results in Figure-6A , sialidase treatment of thymocytes resulted in unmasking of a unique subset of PNAreceptor proteins that were not exposed on mock treated cells ( Figure 6B , arrows, compare top-left and top-right panels). Identical results were obtained using purified CD4 + CD8 + thymocytes (data not shown). As expected, PNA precipitation of splenic T cell surface proteins was markedly increased following sialidase treatment ( Figure 6B , compare bottom-left and bottom-right panels), and most importantly, the same subset of proteins present in PNA precipitates of sialidase treated thymocytes existed in PNA precipitates of sialidase treated splenic T cells ( Figure 6B , arrows, compare top-right and bottom-right panels). Note that reduced amounts of CD8 and CD8-associated proteins (*) were present in PNA precipitates of splenic T cells relative to thymocytes because CD8 is expressed on the vast majority of thymocytes but only a subpopulation of mature splenic T cells (Fowlkes and Pardoll, 1989) . Taken together, these data show that a similar set of polypeptides is variably masked by sialylation throughout T cell development. In addition, these results suggest that certain proteins are constitutively sialylated on T lymphocytes during both PNA" and PNA'° stages of T cell differentiation. The identity of these proteins remains to be established, but do not represent CD4, CD5, CD28, CD43, CD45, or TCR molecules (unpublished observations).
Discussion
In this study, we evaluated the expression of PNA-specific glycans on murine thymocytes at distinct stages of differentiation along the CD4/CD8 developmental pathway. These results demonstrate that expression of PNA-specific glycans is regulated throughout T cell development by posttranslational sialic acid-dependent masking mechanisms that modulate the exposure of terminal galactose saccharides at the cell surface. In addition, these data show that a similar set of proteins bearing PNA-specific glycans is intermittently masked by sialylation during T cell differentiation.
The current study demonstrates that murine thymocytes progress from PNA'^PNA^PNA 10 stages during their development from double-negative-^double positive-^single positive thymocytes, respectively. These findings confirm and extend previous studies on the expression of PNA-specific glycans in human thymus tissue (Gillespie et ai, 1993) . The molecular basis for regulated expression of PNA-specific glycans in murine thymocytes remains to be determined, but most likely involves variable expression of a2,3 O-linked ST enzymes, similar to what has been described in the human system (Gillespie et al., 1993) . Regarding this issue, studies by Lefrancois and colleagues showed that immature murine fetal thymocytes express significant amounts of receptors reactive with the CT monoclonal antibody, which is specific for Gal31,3GalNAc glycans containing a2,3 linked sialic acid (Lefrancois, 1987; Lefrancois et ai, 1987; Conzelmann and Lefrancois, 1988) . However, the data in the current study suggest that expression of PNA-specific glycans in murine T cells may be regulated at several distinct levels in that a subset of PNA receptor proteins was identified that was perpetually masked during both PNA ST, such as ot2,6 O-linked ST (Gillespie et al., 1993; Harduin-Lepers et al., 1995) , remains to be established. It will also be interesting to determine the identity of PNA receptor proteins that are constitutively masked throughout T cell development to see if they are molecules of known immunological function or represent previously unidentified thymocyte proteins. Experiments designed to address these issues are currently in progress.
Finally, the functional significance of regulated expression of PNA-specific glycans on developing T cells is unknown. Current hypotheses suggest that variable sialylation of thymocyte proteins may be important in regulating the egress of thymocytes from the thymic cortex to the thymic medulla or in regulating signal transduction during thymic selection (Gillespie et al., 1993; Sharon, 1983) . Regarding this issue, we (Wu et al., 1996) and others (Brown and Williams, 1982; De Petris and Takacs, 1983; Favero et al., 1984; De Maio et al., 1986) have noted that several molecules of major immunological importance contain PNA-specific glycans, which conceivably could function in intrathymic selection processes via interaction with endogenous galactose-specific lectins, such as CD23 (Kijimoto-Ochiai and Uede, 1995) . Moreover, given the recent finding that redundant pathways exist for the synthesis of Gaipi,3GalNAc glycans in T lymphocytes (Hennet et al., 1995) , it is reasonable to speculate that PNA-specific saccharides play an important role in the development and function of T cells within the immune system.
Materials and methods

Animals and cell preparation
C57BL/6 (B6) mice 6-8 weeks of age were obtained from the Jackson Laboratory (Bar Harbor, ME). The generation of RAG -/-mice has been described (Shinkai et al, 1992) , which were kindly provided by Dr. Alfred Singer (NIH, Bethesda, MD). CD4 + CD8 + thymocytes were isolated by their adherence to plastic plates coated with anti-CD8 mAb (83-12-5) as previously described (Kearse et al, 1994) . Purified splenic T cells were obtained by incubating single cell suspensions of spleen cells on rabbit anti-mouse immunoglobulin (Organon Technika-Cappel, Malvern, PA)-coated tissue cultured plates for 60 min at 37°C, followed by isolation of nonadherent cells as previously detailed (Kearse et al, 1994) .
Reagents and antibodies
Immobilized and fluorescent-labeled lectins were purchased from EY Laboratories (EY Laboratories, San Diego, CA). Galactose, mannose, glucose saccharides and benzyl 2-acetamido-a-2-deoxy-D-galactopyranoside (B-GalNAc) and Benzyl 2-acetamido-a-2-deoxy-D-glucopyranoside (B-GlcNAc) were obtained from Sigma Chemical Co. (Sigma, St. Louis, MO).
Surface biotin-labeling and lectin affinity chromatography
Surface biotin labeling was performed as previously described (Wu et al, 1996) . Briefly, cells were washed 2x in cell wash buffer (PBS containing 1 mM MgCl 2 and 100 u-M CaCl 2 ), resuspended in wash buffer containing 1 mg/ml sulfo-NHS biotin (Pierce, Rockford, IL), and incubated at 4°C for 30 min. Biotin labeling was terminated by washing cells 2x in wash buffer containing 25 mM lysine. Surface biotin-labelcd proteins were analyzed on SDS-PAGE gels, transferred to nitrocellulose membrane (Immobilon-P, Millipore, Bedford, MA), and detected by streptavidin conjugated to horseradish peroxidase and chemiluminescence reagents, performed according to manufacturer's instructions (Renaissance Chemiluminescence Reagent; (Dupont-NEN, Boston, MA). For lectin chromatography, cells were solubilized in 1% NP-40 lysis buffer (20 mM Tris, 150 mM NaCl, 10 mM iodoacetamide, 20 u.g/ml leupeptin, 40 u-g/ml aprotinin) for 20 min at 4°C; insoluble material was clarified by centrifugan'on and lysates were precipitated with peanut agglutinin (PNA)-conjugated agarose beads (EY Laboratories, San Mateo, CA) as described (Wu etal. 1996) .
Benzyl-GalNac/GlcNAc treatment, sialidase treatment, and gtycosidase digestions
For benzyl-GalNAc/GlcNAc treatment, purified splenic T cells were cultured for 10-12 h at 5 x 10 5 to 1 x 10 6 cells/ml in RPMI medium (Life Technologies, Grand Island, NY) containing 5% inactivated fetal calf serum (FCS) with or without 5 mM B-GalNAc/GlcNAc at 37°C in 5% CO 2 . For sialidase treatment of intact cells, cells were washed 2x in RPMI medium without FCS, resuspended in RPMI at a density of 1 x 10* cells/ml, and incubated at 37°C for 30 min in the presence of 10-20 mil of sialidase (Vibrio cholerae; Boehringer Mannheim, Indianapolis, IN). Sialidase treatment was terminated by washing cells 2x in RPMI containing 10% FCS at 4°C. Viability was identical in untreated and sialidase treated groups (data not shown). Glycosidase digestions were performed using an enzymatic deglycosylation kit (Glyko Inc., Novato, CA), carried out according to manufacturer's instructions.
Flow cytometry
Cells (1 x 10 6 ) were incubated with fluorescence-labeled lectins (10 p-g/ml) in Hank's Buffered Saline Solution (HBSS), (Life Technologies, Grand Island, NY) for 30 min at 4°C, washed twice in HBSS, and analyzed on FACSTAR and FACSSCAN (Becton Dickinson & Co., Mountain View, CA) flow cytometers. All fluorescence data were collected using logarithmic amplification on 50,000 viable cells as determined by forward light scatter intensity and propidium iodide exclusion. Negative control staining was performed using HBSS or FTTC-and biotin-labeled Leu4 mAb to human CD3 which does not react with murine cells; staining with HBSS or fluorescence-conjugated control Abs was equivalent (data not shown).
